Insoluble Particle Testing for Single-Use Syringes: Methods, Standards, and Applications

Insoluble particle testing is a critical quality control procedure for single-use syringes, ensuring that sub-visible particles released from the barrel, plunger, or needle components do not pose a risk to patients receiving injections. This article explains the technical principles, sample preparation, test methods, and regulatory standards—such as ISO 7886-1, GB 15810, and USP <788>—that govern insoluble particle evaluation for disposable sterile syringes.

Technical Overview

Insoluble particles (also called sub-visible particulate matter) are small, undissolved contaminants that may be shed from the internal surfaces of a single-use syringe during use. These particles can originate from plastic molding residues, rubber or elastomer piston fragments, silicone lubricant agglomerates, manufacturing debris, environmental contamination during assembly or packaging, or degradation caused by sterilization processes. Because syringes deliver medications directly into tissues or the bloodstream, particulate contamination carries serious clinical risks, including venous inflammation, phlebitis, microembolism, granuloma formation, and tissue irritation.

Insoluble particle testing evaluates the quantity and size distribution of particles released from a syringe when its interior is rinsed with particle-free water under controlled conditions. The test is typically performed in an ISO Class 5 (Class 100) laminar flow environment using calibrated instrumentation. The governing references include ISO 7886-1 (Sterile hypodermic syringes for single use), GB 15810 (the Chinese national standard for sterile single-use syringes), the Chinese Pharmacopoeia General Chapter 0903 (Insoluble Particles Test), USP <788> (Particulate Matter in Injections), and calibration requirements aligned with ISO 21501-2 for light obscuration sensors.

Testing Samples

Sterile Single-Use Hypodermic Syringes

The primary test article is the finished sterile syringe, with or without an attached needle, taken from the production lot in its final packaged and sterilized state. Testing the complete finished product ensures that all contributors to particle burden—including molding, assembly, siliconization, and sterilization—are captured.

Specialty Syringe Types

Additional sample types include insulin syringes, tuberculin syringes, low-dead-space syringes, auto-disable syringes, safety syringes, and prefilled syringe systems or their component parts (barrels, plungers, stoppers). Each configuration may require an adapted rinse procedure appropriate to its internal geometry and nominal capacity.

Sampling and Conditioning

Samples should be selected according to a statistically justified sampling plan from each production batch. Prior to testing, units are acclimated to the laboratory environment, the outer packaging is opened inside the clean workstation, and all subsequent handling is performed with powder-free gloves and particle-free tools to prevent adventitious contamination.

Testing Items

The core test items assessed during insoluble particle evaluation include:

• Cumulative count of particles equal to or larger than 10 micrometers (µm) released per syringe or per milliliter of rinse fluid
• Cumulative count of particles equal to or larger than 25 µm released per syringe or per milliliter of rinse fluid
• Optional monitoring of finer fractions, such as particles equal to or larger than 5 µm, for process characterization or research purposes
• Blank control values, using particle-free water handled identically to the samples but without a test syringe
• Net particle burden, calculated by subtracting the blank background from the gross sample counts
• Conformity determination against the acceptance criteria defined in the applicable product standard or registered product specification

Testing Methods

Light Obscuration Method (Light Extinction Particle Counting)

The light obscuration method is the preferred first-line technique. A calibrated liquid particle counter draws the sample fluid through a sensor in which a laser or collimated light beam illuminates a flow cell. When a particle passes through the sensing zone, it interrupts a portion of the light, and the resulting voltage pulse is proportional to the particle's projected cross-sectional area. Instrument calibration and sensor resolution are verified using traceable standard particles in accordance with ISO 21501-2, USP <788>, or Chinese Pharmacopoeia Chapter 0903.

Typical test procedure:

• Clean the exterior of the syringe and its packaging before introducing them into the ISO Class 5 workstation
• Draw particle-free, ultrafiltered water into the syringe to its nominal capacity
• Recap or close the tip, invert, rotate, and agitate the syringe so the water fully wets all interior surfaces, including the barrel wall and piston contact area
• Expel the rinse fluid into a clean collection vessel; repeat rinses or pool multiple units as required by the applicable method
• Run a blank control through the identical sequence without a syringe
• Measure the collected fluid, recording particle counts at the 10 µm and 25 µm thresholds, and correct for the blank background

Microscopic Membrane Count Method

When the sample is unsuitable for light obscuration—for example, when silicone oil droplets, high viscosity, or bubble interference is suspected—the membrane filtration microscopy method is applied. The rinse fluid is filtered through a gridded membrane filter with a fine pore size (typically 0.45 µm). The membrane is dried, made transparent, and examined under a calibrated microscope. Particles within defined size ranges are counted manually or with image analysis software, and their morphology (fibers, flakes, elastomer fragments, droplets) can be recorded, which supports contamination source investigations.

Environmental and Quality Controls

Regardless of the counting technique, rigorous controls are essential. The test station must be an ISO Class 5 laminar flow hood, glassware must be sequentially cleaned with particle-free water and verified by background checks, and the particle-free water itself must meet strict baseline limits before use. All measurements are performed after system suitability verification, and results are only reported when blank values remain within the permitted threshold.

Applications

Insoluble particle testing supports multiple quality and regulatory objectives across the product lifecycle:

• Batch release testing for manufacturers of disposable sterile syringes as part of routine quality control
• Product registration and regulatory submissions to authorities such as NMPA, FDA, and notified bodies under the EU MDR
• Validation of manufacturing processes, including injection molding, siliconization, assembly, and packaging
• Evaluation of sterilization methods (ethylene oxide, gamma irradiation, electron beam) and their effect on particle generation
• Change control assessments when materials, suppliers, lubricants, or designs are modified
• Root cause investigation of contamination incidents and complaints, using microscopy for particle identification
• Comparative studies of elastomer formulations, coating technologies, and lubrication strategies
• Stability and shelf-life studies to confirm that particle levels remain acceptable throughout the labeled storage period

FAQ

Why is the syringe rinsed with particle-free water instead of testing a real drug product?

The rinse method simulates a reproducible worst-case extraction of particles from all interior surfaces that contact the medication, independent of drug formulation. It provides a consistent, comparable metric for quality control, whereas actual drug products vary in viscosity, chemistry, and compatibility.

What are the typical acceptance limits?

Limits are defined by the applicable product standard and the manufacturer's registered specification. ISO 7886-1 and GB 15810 specify maximum permissible particle counts released per syringe, commonly evaluated at the 10 µm and 25 µm thresholds. As a widely referenced benchmark for small-volume injectables, USP <788> sets limits of no more than 6,000 particles at or above 10 µm and 600 particles at or above 25 µm per container.

Can silicone oil interfere with the results?

Yes. Silicone oil used as a barrel lubricant can form droplets that are detected as particles by light obscuration. If oil droplets are suspected of inflating counts, the microscopic membrane method is used to distinguish droplets from solid debris and to support corrective action.

How many syringes should be tested?

The sample size follows the sampling plan specified in the applicable standard or the manufacturer's validated procedure. Multiple units are typically tested, and their rinses may be pooled or measured individually, with blank controls run in parallel for every test session.

What happens if a batch fails the test?

A failing result triggers a deviation investigation covering water and glassware backgrounds, instrument calibration, operator technique, and finally the product itself. Root causes such as piston defects, molding flash, excessive siliconization, or sterilization degradation are identified and corrected before the batch is dispositioned.